SHTPY · SCHOTT Pharma AG & Co. KGaA/ADR · Analyst Estimates
Market Cap
$3.95B
Shares
602.46M
Analyst Estimates
Compare analyst forecasts for SCHOTT Pharma AG & Co. KGaA/ADR across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 17:32 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-09-30
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
EUR
Publication date not stated |
1021000000
|
1040016590
|
1051175810
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
10
|
FY ending 2027-09-30
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
EUR
Publication date not stated |
1076638500
|
1101638790
|
1143477720
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
12
|
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
EUR
Publication date not stated |
279815140
|
280545480
|
281275810
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
2
|
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
EUR
Publication date not stated |
265028800
|
265028800
|
265028800
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
1
|